How Flaviviruses Activate and Suppress the Interferon Response.
- Published in:
- Viruses (1999-4915), 2010, v. 2, n. 2, p. 676, doi. 10.3390/v2020676
- By:
- Publication type:
- Article
Works matching IS 19994915 AND DT 2010 AND VI 2 AND IP 2
Results: 16
1
2
Restriction of Rift Valley Fever Virus Virulence in Mosquito Cells.
- Published in:
- Viruses (1999-4915), 2010, v. 2, n. 2, p. 655, doi. 10.3390/v2020655
- By:
- Publication type:
- Article
3
The Evolution of HIV-1 Diversity in Rural Cameroon and its Implications in Vaccine Design and Trails.
- Published in:
- Viruses (1999-4915), 2010, v. 2, n. 2, p. 639, doi. 10.3390/v2020639
- By:
- Publication type:
- Article
4
Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase.
- Published in:
- Viruses (1999-4915), 2010, v. 2, n. 2, p. 606, doi. 10.3390/v2020606
- By:
- Publication type:
- Article
5
Surface Transmission or Polarized Egress? Lessons Learned from HTLV Cell-to-Cell Transmission.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
6
CCR5: From Natural Resistance to a New Anti-HIV Strategy.
- Published in:
- Viruses (1999-4915), 2010, v. 2, n. 2, p. 574, doi. 10.3390/v2020574
- By:
- Publication type:
- Article
7
A Host of Factors Regulating Influenza Virus Replication.
- Published in:
- Viruses (1999-4915), 2010, v. 2, n. 2, p. 566, doi. 10.3390/v2020566
- By:
- Publication type:
- Article
8
Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins.
- Published in:
- Viruses (1999-4915), 2010, v. 2, n. 2, p. 547, doi. 10.3390/v2020547
- By:
- Publication type:
- Article
9
Developing Vaccines to Combat Pandemic Influenza.
- Published in:
- Viruses (1999-4915), 2010, v. 2, n. 2, p. 532, doi. 10.3390/v2020532
- By:
- Publication type:
- Article
10
HIV Genetic Diversity and Drug Resistance.
- Published in:
- Viruses (1999-4915), 2010, v. 2, n. 2, p. 503, doi. 10.3390/v2020503
- By:
- Publication type:
- Article
11
PEGylated Adenoviruses: From Mice to Monkeys.
- Published in:
- Viruses (1999-4915), 2010, v. 2, n. 2, p. 468, doi. 10.3390/v2020468
- By:
- Publication type:
- Article
12
Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials.
- Published in:
- Viruses (1999-4915), 2010, v. 2, n. 2, p. 435, doi. 10.3390/v2020435
- By:
- Publication type:
- Article
13
RNA Replicons - A New Approach for Influenza Virus Immunoprophylaxis.
- Published in:
- Viruses (1999-4915), 2010, v. 2, n. 2, p. 413, doi. 10.3390/v2020413
- By:
- Publication type:
- Article
14
Lentiviral Vectors and Cystic Fibrosis Gene Therapy.
- Published in:
- Viruses (1999-4915), 2010, v. 2, n. 2, p. 395, doi. 10.3390/v2020395
- By:
- Publication type:
- Article
15
The Role of Nucleotide Excision by Reverse Transcriptase in HIV Drug Resistance.
- Published in:
- Viruses (1999-4915), 2010, v. 2, n. 2, p. 372, doi. 10.3390/v2020372
- By:
- Publication type:
- Article
16
Development of Viral Vectors for Use in Cardiovascular Gene Therapy.
- Published in:
- Viruses (1999-4915), 2010, v. 2, n. 2, p. 334, doi. 10.3390/v2020334
- By:
- Publication type:
- Article